Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin in Renal Transplant Recipients With Low LDL-cholesterol
NCT00223041Phase 3Terminated
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Apr 2003
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluvastatin in cardiovascular disease (CVD), sponsored by Universitätsklinikum Schleswig-Holstein. Started Apr 2003; status: terminated.
02
Drugs
fluvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00223041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223041.